These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 7706756
1. Hyperinducibility of HLA class II expression of thyroid follicular cells from Graves' disease. A primary defect? Sospedra M, Obiols G, Babi LF, Tolosa E, Vargas F, Roura-Mir C, Lucas-Martin A, Ercilla G, Pujol-Borrell R. J Immunol; 1995 Apr 15; 154(8):4213-22. PubMed ID: 7706756 [Abstract] [Full Text] [Related]
2. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice. Kawai K, Enomoto T, Fornasier V, Resetkova E, Volpé R. Proc Assoc Am Physicians; 1997 Mar 15; 109(2):126-35. PubMed ID: 9069581 [Abstract] [Full Text] [Related]
3. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease. Matsunaga M, Eguchi K, Fukuda T, Kurata A, Tezuka H, Shimomura C, Otsubo T, Ishikawa N, Ito K, Nagataki S. J Clin Endocrinol Metab; 1986 Apr 15; 62(4):723-8. PubMed ID: 3081570 [Abstract] [Full Text] [Related]
4. Occurrence of thyrocyte HLA class II expression in a wide variety of thyroid diseases: relationship with lymphocytic infiltration and thyroid autoantibodies. Lucas-Martin A, Foz-Sala M, Todd I, Bottazzo GF, Pujol-Borrell R. J Clin Endocrinol Metab; 1988 Feb 15; 66(2):367-75. PubMed ID: 3276724 [Abstract] [Full Text] [Related]
5. Thyrocyte HLA-DR expression and interferon-gamma production in autoimmune thyroid disease. Iwatani Y, Gerstein HC, Iitaka M, Row VV, Volpé R. J Clin Endocrinol Metab; 1986 Sep 15; 63(3):695-708. PubMed ID: 3090094 [Abstract] [Full Text] [Related]
7. Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre. Jansson R, Karlsson A, Forsum U. Clin Exp Immunol; 1984 Nov 15; 58(2):264-72. PubMed ID: 6238731 [Abstract] [Full Text] [Related]
8. HLA-D subregion expression by thyroid epithelium in autoimmune thyroid diseases and induced in vitro. Todd I, Pujol-Borrell R, Abdul-Karim BA, Hammond LJ, Feldmann M, Bottazzo GF. Clin Exp Immunol; 1987 Sep 15; 69(3):532-42. PubMed ID: 3117460 [Abstract] [Full Text] [Related]
9. Enhancement of thyrocyte HLA class II expression by thyroid stimulating hormone. Todd I, Pujol-Borrell R, Hammond LJ, McNally JM, Feldmann M, Bottazzo GF. Clin Exp Immunol; 1987 Sep 15; 69(3):524-31. PubMed ID: 2822302 [Abstract] [Full Text] [Related]
10. Epidermal growth factor and transforming growth factor-alpha suppress HLA class II induction in human thyroid epithelial cells. Todd I, Hammond LJ, James RF, Feldmann M, Bottazzo GF. Immunology; 1990 Jan 15; 69(1):91-6. PubMed ID: 2107145 [Abstract] [Full Text] [Related]
11. The interaction of MHC and Gm in liability to autoimmune thyroid disease. Nagataki S. Mol Biol Med; 1986 Feb 15; 3(1):73-84. PubMed ID: 3007922 [Abstract] [Full Text] [Related]
12. Interaction of lymphocytes and thyrocytes in Graves' disease and nonautoimmune thyroid diseases in immunohistochemical and ultrastructural investigations. Ben-Skowronek I, Sierocinska-Sawa J, Szewczyk L, Korobowicz E. Horm Res; 2009 Feb 15; 71(6):350-8. PubMed ID: 19506393 [Abstract] [Full Text] [Related]
13. Antibodies specific for human thyrotropin receptor induce MHC antigen expression in thyroid cells. Ropars A, Marion S, Takorabet L, Braun J, Charreire J. J Immunol; 1994 Oct 01; 153(7):3345-52. PubMed ID: 8089502 [Abstract] [Full Text] [Related]
15. Specific stimulation of Graves' disease thyrocytes by the natural anti-Gal antibody from normal and autologous serum. Winand RJ, Devigne JW, Meurisse M, Galili U. J Immunol; 1994 Aug 01; 153(3):1386-95. PubMed ID: 8027563 [Abstract] [Full Text] [Related]
16. Immunopathological findings and thyroid autoantibodies in thyroid autonomy. Bretzel RG, Platzer A, Schaeffer R. Acta Med Austriaca; 1990 Aug 01; 17 Suppl 1():20-4. PubMed ID: 2202177 [Abstract] [Full Text] [Related]
17. Inappropriate major histocompatibility complex class II expression by thyroid follicular cells in thyroid autoimmune disease and by pancreatic beta cells in type I diabetes. Pujol-Borrell R, Todd I, Londei M, Foulis A, Feldmann M, Bottazzo GF. Mol Biol Med; 1986 Apr 01; 3(2):159-65. PubMed ID: 3090400 [Abstract] [Full Text] [Related]
18. Overexpression of metallothionein I/II: a new feature of thyroid follicular cells in Graves' disease. Ruiz-Riol M, Martínez-Arconada MJ, Alonso N, Soldevila B, Marchena D, Armengol MP, Sanmartí A, Pujol-Borrell R, Martínez-Cáceres EM. J Clin Endocrinol Metab; 2012 Feb 01; 97(2):446-54. PubMed ID: 22090273 [Abstract] [Full Text] [Related]
19. Application of mouse monoclonal antibodies for identification of antigen regions of human thyroid peroxidase in adolescents with Graves' disease and non-toxic multinodular goiter by flow cytometry. Bossowski A, Stasiak-Barmuta A, Czarnocka B, Urban M, Dadan J. Autoimmunity; 2005 Dec 01; 38(8):605-11. PubMed ID: 16390813 [Abstract] [Full Text] [Related]
20. Expression of Bcl-2 family proteins in thyrocytes from young patients with immune and nonimmune thyroid diseases. Bossowski A, Czarnocka B, Bardadin K, Urban M, Niedziela M, Dadan J. Horm Res; 2008 Dec 01; 70(3):155-64. PubMed ID: 18663316 [Abstract] [Full Text] [Related] Page: [Next] [New Search]